AU2002368315A1 - A method for normalizing insulin levels - Google Patents

A method for normalizing insulin levels

Info

Publication number
AU2002368315A1
AU2002368315A1 AU2002368315A AU2002368315A AU2002368315A1 AU 2002368315 A1 AU2002368315 A1 AU 2002368315A1 AU 2002368315 A AU2002368315 A AU 2002368315A AU 2002368315 A AU2002368315 A AU 2002368315A AU 2002368315 A1 AU2002368315 A1 AU 2002368315A1
Authority
AU
Australia
Prior art keywords
insulin levels
normalizing insulin
normalizing
levels
insulin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002368315A
Inventor
David Linda G. I. Chapnick
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Quality Vitamins Inc
Original Assignee
Quality Vitamins Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quality Vitamins Inc filed Critical Quality Vitamins Inc
Publication of AU2002368315A1 publication Critical patent/AU2002368315A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7012Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AU2002368315A 2002-10-25 2002-11-07 A method for normalizing insulin levels Abandoned AU2002368315A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/280,332 US6896914B2 (en) 2001-10-26 2002-10-25 Method for normalizing insulin levels
US10/280,332 2002-10-25
PCT/US2002/035636 WO2004039356A1 (en) 2002-10-25 2002-11-07 A method for normalizing insulin levels

Publications (1)

Publication Number Publication Date
AU2002368315A1 true AU2002368315A1 (en) 2004-05-25

Family

ID=32228748

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002368315A Abandoned AU2002368315A1 (en) 2002-10-25 2002-11-07 A method for normalizing insulin levels

Country Status (4)

Country Link
US (2) US6896914B2 (en)
EP (1) EP1562554A1 (en)
AU (1) AU2002368315A1 (en)
WO (1) WO2004039356A1 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060116330A1 (en) * 1997-07-08 2006-06-01 The Iams Company Methods of mimicking the metabolic effects of caloric restriction by administration of mannoheptulose
US20020035071A1 (en) * 1997-07-08 2002-03-21 Josef Pitha Mimicking the metabolic effects of caloric restriction by administration of glucose antimetabolites
US8563522B2 (en) * 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
US7666459B2 (en) * 2001-09-12 2010-02-23 The Procter & Gamble Company Pet food compositions
US20050164978A1 (en) * 2001-10-26 2005-07-28 Chapnick David I. Method for normalizing insulin levels
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
EP1731357A4 (en) * 2004-02-02 2009-03-04 Daihatsu Motor Co Ltd Automobile seat
FR2869541B1 (en) * 2004-04-30 2007-12-28 Expanscience Sa Lab USE OF A COMPOSITION COMPRISING D-MANNOHEPTULOSE AND / OR PERSEITOL FOR THE TREATMENT AND PREVENTION OF DISEASES ASSOCIATED WITH A CHANGE IN INITIATED IMMUNITY
US20090252834A1 (en) * 2004-05-10 2009-10-08 Michael Griffin Hayek Compositions comprising glucose anti-metabolites
US20050249837A1 (en) * 2004-05-10 2005-11-10 The Procter & Gamble Company Processes for preparing plant matter extracts and pet food compositions
CA2609617C (en) * 2005-05-31 2014-07-08 The Iams Company Feline probiotic lactobacilli
AR053805A1 (en) * 2005-05-31 2007-05-23 Iams Company PROBIOTIC BIFIDOBACTERIES FOR FELINOS
EP2124969A2 (en) * 2007-02-01 2009-12-02 The Iams Company Method for decreasing inflammation and oxidative stress in mammals
CA2673465A1 (en) * 2007-02-01 2008-08-07 The Iams Company Method for decreasing inflammation and stress in a mammal
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
FR2953722B1 (en) 2009-12-16 2012-03-09 Expanscience Lab COMPOSITION COMPRISING AT LEAST ONE C7 SUGAR FOR THE TREATMENT OF ALOPECIA, FOR THE COSMETIC TREATMENT OF PHANES, AND FOR THE CARE OF HAIR, CILES OR NAILS
WO2012012390A1 (en) 2010-07-19 2012-01-26 Marvphyt Development Llc Botanical composition and methods of manufacture and use
FR3001889B1 (en) 2013-02-11 2021-02-12 Expanscience Lab USE OF A COMPOSITION CONTAINING AVOCADO PERSEOSE IN THE PROTECTION OF EPIDERMAL STEM CELLS.
CN105209046A (en) * 2013-03-15 2015-12-30 爱默思公司 A composition comprising mannoheptulose for use in the treatment or prevention of overweight and obesity
US20140349002A1 (en) * 2013-05-23 2014-11-27 The Iams Company Ingestible Compositions Containing Criollo Avocado Component
WO2018031286A1 (en) * 2016-08-08 2018-02-15 Yale University Compositions and methods of treatment using glucose analogs

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS608000B2 (en) * 1980-04-11 1985-02-28 呉羽化学工業株式会社 Aminophenyl derivatives and bioactive agents containing the derivatives
US5344824A (en) * 1990-02-02 1994-09-06 Matsutani Chemical Industries Co., Ltd. Method for reducing insulin secretion
US20020035071A1 (en) * 1997-07-08 2002-03-21 Josef Pitha Mimicking the metabolic effects of caloric restriction by administration of glucose antimetabolites
US6926911B1 (en) * 1998-12-22 2005-08-09 The University Of North Carolina At Chapel Hill Compounds and methods for the treatment of airway diseases and for the delivery of airway drugs
US6319510B1 (en) * 1999-04-20 2001-11-20 Alayne Yates Gum pad for delivery of medication to mucosal tissues

Also Published As

Publication number Publication date
US20040228933A1 (en) 2004-11-18
US20030092669A1 (en) 2003-05-15
US6896914B2 (en) 2005-05-24
EP1562554A1 (en) 2005-08-17
WO2004039356A1 (en) 2004-05-13

Similar Documents

Publication Publication Date Title
AU2002368315A1 (en) A method for normalizing insulin levels
AU2003208489A1 (en) Method for desinging a well completion
AU2003253024A1 (en) Method for training a learning-capable system
AU2003276045A1 (en) Method of solving a split-brain condition
AU2003216220A1 (en) Method for securing a headset
AU2003303003A1 (en) Method for a mosaic program guide
AU2003211090A1 (en) Overerase correction method
AU2002952193A0 (en) A method for providing online insurance
AU2002357486A1 (en) Localisation method
AU2003246683A1 (en) Method for calculating a transmission window size
AU2003219148A1 (en) Method for operating a turbine
AU2003203030A1 (en) Method for maintaining communication with a device
AU2003296221A1 (en) A general charging method
AU2003258070A1 (en) Electrodionization method
AU2003210042A1 (en) A method for preparing organic fluorocompounds
AU2003205939A1 (en) Turboblower and method for operating such a turboblower
AU2003207383A1 (en) Management method
AU2003223855A1 (en) Method for operating a call-centre
AU2003257469A1 (en) Well, and method for regenerating a well
AU2003243355A1 (en) Method for providing a pre-security depository
AU2003255554A1 (en) A method for bricklaying
AU2003263714A1 (en) Method for obtaining a fraction
AU2003253813A1 (en) Method for colpoplasty
AU2003299652A1 (en) Methods for treating diabetes
AU2003261577A1 (en) A language-code input method

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase